AMPH
Amphastar Pharmaceuticals Inc

1,126
Mkt Cap
$1.4B
Volume
524,386.00
52W High
$46.43
52W Low
$20.39
PE Ratio
11.25
AMPH Fundamentals
Price
$25.37
Prev Close
$25.90
Open
$25.81
50D MA
$25.72
Beta
0.69
Avg. Volume
363,631.35
EPS (Annual)
$3.06
P/B
1.51
Rev/Employee
$360,930.47
Loading...
Loading...
News
all
press releases
Floyd Petersen Sells 16,679 Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) Director Floyd Petersen sold 16,679 shares of the stock in a transaction that occurred on Thursday, November 13th. The shares were sold...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Amphastar Pharmaceuticals (NASDAQ:AMPH) Director Floyd Petersen Sells 16,679 Shares
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) Director Floyd Petersen sold 16,679 shares of Amphastar Pharmaceuticals stock in a transaction dated Thursday, November 13th. The stock...
MarketBeat·2d ago
News Placeholder
21,199 Shares in Amphastar Pharmaceuticals, Inc. $AMPH Acquired by Fox Run Management L.L.C.
Fox Run Management L.L.C. purchased a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the second quarter, according to the company in its most recent...
MarketBeat·8d ago
News Placeholder
Validea Peter Lynch Strategy Daily Upgrade Report - 11/11/2025
The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to...
Nasdaq News: Markets·9d ago
News Placeholder
Amphastar Pharmaceuticals (NASDAQ:AMPH) Issues Quarterly Earnings Results, Beats Estimates By $0.10 EPS
Amphastar Pharmaceuticals (NASDAQ:AMPH - Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.93 EPS for the quarter, beating analysts' consensus estimates of...
MarketBeat·11d ago
News Placeholder
Y Intercept Hong Kong Ltd Purchases Shares of 17,727 Amphastar Pharmaceuticals, Inc. $AMPH
Y Intercept Hong Kong Ltd acquired a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the 2nd quarter, according to its most recent filing with the Securities...
MarketBeat·11d ago
News Placeholder
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Recommendation of "Moderate Buy" from Analysts
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the seven analysts that are covering the company, Marketbeat.com...
MarketBeat·11d ago
News Placeholder
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Up Following Strong Earnings
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Up After Better-Than-Expected Earnings...
MarketBeat·12d ago
News Placeholder
Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings
The headline numbers for Amphastar (AMPH) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·14d ago
News Placeholder
Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Top Estimates
Amphastar (AMPH) delivered earnings and revenue surprises of +20.78% and +3.96%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago

Latest AMPH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.